No need to file Corporate Governance report; zero investor complaints in Q2

Compliance View source PDF Explain this filing

INFINIUM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹312.50

prior close

₹312.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+0.6% vs market

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.8

10m

+3.8

15m

+3.8

30m

+3.8

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+1.4+0.8+0.6

Next day

-3.4+1.0-4.4

-3.4+1.7-5.1

+0.5+0.1+0.4

-2.4+0.8-3.2

-4.2-0.9-3.3

-5.1-4.5-0.6

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Infinium Pharmachem says it is exempt from submitting the quarterly Corporate Governance report under SEBI's Reg 27(2) because its shares are listed on the SME exchange. Separately, the registrar (Bigshare Services) reported zero investor complaints received, resolved, or pending for the quarter ended 30 Sep 2026.

Likely market impact

Routine compliance filing with no material effect on business or shareholders.